Michael J. Manyak

Directeur Technique/Scientifique/R&D chez Jazz Pharmaceuticals (EUSA Pharma USA), Inc.

Profil

Michael J.
Manyak joined Cytogen Corp.
in January 2005 as Vice President of Medical Affairs.
Prior to joining Cytogen, he was Professor of Urology, Microbiology and Tropical Medicine at The George Washington University Medical Center, where he was Chairman of the Department of Urology.
After completing his urological residency at GWUMC, he became an American Foundation for Urological Disease Scholar at the National Cancer Institute and joined the urological staff at GWUMC.
Dr. Manyak has served on the Medicare Coverage Advisory Committee for the Center for Medicare and Medicaid Services, where he was a Member of the Imaging Subcommittee.
He received a presidential appointment to the National Kidney and Urological Disease Advisory Board and was a Voting Member of the Food and Drug Administration Regulatory Panel for Genitourinary and Gastrointestinal Devices.
Dr. Manyak has been a Reviewer for the NIH Special Study Section for Small Business Grants.
He received a BA from the University of Notre Dame and an MD from the University of the East, Manila, Phillipines.

Postes actifs de Michael J. Manyak

Sociétés	Poste	Début
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.	Directeur Technique/Scientifique/R&D	-

Anciens postes connus de Michael J. Manyak

Sociétés	Poste	Fin
Viking Systems, Inc.	Directeur/Membre du Conseil	06/10/2007

Formation de Michael J. Manyak

University of Notre Dame

Undergraduate Degree